中國恆大(03333.HK):倘分拆恆大物業得以進行 擬向合資格股東提供優先認股權
中國恆大(03333.HK)公布,公司擬通過將恆大物業股份於聯交所主機板獨立上市的方式分拆恆大物業。就建議分拆而言,恆大物業將進行全球發售,當中包括香港公開發售及國際發售(包括優先發售)。根據上市規則第15項應用指引的規定,倘建議分拆得以進行,董事會建議透過以優先發售的方式向合資格股東提供獲得恆大物業股份的保證配額,以顧及股東利益。有關建議分拆的詳情尚未落實,將適時刊發進一步公告。
為釐定合資格股東於優先發售中獲得恆大物業股份保證配額的記錄日期將為2020年11月18日(星期三)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.